Name | Type | Posted | Actions |
|---|---|---|---|
Ebola virus_Therapeutic_SSN-BARDA-02202026.pdf | Feb 20, 2026 |
FDA Licensed Ebola Virus Therapeutics
Contact and place of performance
Yifan Yang
USA
The Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR) at the United States (U.S.) Department of Health and Human Services (HHS), is issuing this SSN to collect feedback from current and potential biopharmaceutical partners. Information collected from this SSN will serve as continued market research for possible future acquisitions and programs.
The Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), is seeking information regarding FDA-licensed Ebola virus therapeutics. This sources sought notice serves as continued market research to gather feedback from current and potential biopharmaceutical partners to inform possible future acquisitions and programs. The requirement is classified under PSC 6505 for Drugs and Biologicals and does not currently utilize a set-aside.
The government is accepting responses for this market research through March 13, 2026. The place of performance is located within the United States. Technical and administrative details regarding this notice, identified by solicitation number BARDA-CBRN-022026, are further detailed in a single PDF attachment titled Ebola virus_Therapeutic_SSN-BARDA-02202026.pdf, which was issued on February 20, 2026. Yifan Yang is the designated point of contact for this inquiry.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.